Spots Global Cancer Trial Database for Electronic Study for Anastrozole Pharmacovigilance Evaluation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Electronic Study for Anastrozole Pharmacovigilance Evaluation
Official Title: Electronic Study for Anastrozole Pharmacovigilance Evaluation
Study ID: NCT00558168
Conditions
Interventions
Study Description
Brief Summary: Collecting information regarding adverse events from patients on treatment with anastrazole with early stage breast cancer
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Nejdet Uskent
Affiliation: Kadir Has University Medical School
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
